Cargando…
Molecular downstaging: a new paradigm for neoadjuvant endocrine therapy
Autores principales: | Ferraro, Emanuela, Fornier, Monica N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812196/ https://www.ncbi.nlm.nih.gov/pubmed/33490206 http://dx.doi.org/10.21037/atm-20-5406 |
Ejemplares similares
-
Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy—does it lead to prolonged survival?
por: Tachibana, Isamu, et al.
Publicado: (2020) -
Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers
por: Ismaili, Nabil
Publicado: (2020) -
Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
por: Kamarajah, S. K., et al.
Publicado: (2020) -
Endocrine hypertension: Changing paradigm in the new millennium
por: Baruah, Manash P., et al.
Publicado: (2011) -
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
por: Kohl, Valerie K. B., et al.
Publicado: (2022)